|
1
|
Bellver J, Rodríguez-Tabernero L, Robles
A, Muñoz E, Martínez F, Landeras J, García-Velasco J, Fontes J,
Álvarez M, Álvarez C, et al: Polycystic ovary syndrome throughout a
woman's life. J Assist Reprod Genet. 35:25–39. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tanbo T, Mellembakken J, Bjercke S, Ring
E, Åbyholm T and Fedorcsak P: Ovulation induction in polycystic
ovary syndrome. Acta Obstet Gynecol Scand. 97:1162–1167.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Palomba S, Falbo A, Russo T and Zullo F:
Ovulation induction in anovulatory patients with polycystic ovary
syndrome. Current Drug Therapy. 1:91–105. 2006.
|
|
4
|
Escobar-Morreale HF: Polycystic ovary
syndrome: Definition, aetiology, diagnosis and treatment. Nat Rev
Endocrinol. 14:270–284. 2018.
|
|
5
|
Zahra M, Shah M, Ali A and Rahim R:
Effects of metformin on endocrine and metabolic parameters in
patients with polycystic ovary syndrome. Horm Metab Res.
49:103–108. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Morley LC, Tang T, Yasmin E, Norman RJ and
Balen AH: Insulin-sensitising drugs (metformin, rosiglitazone,
pioglitazone, D-chiro-inositol) for patients with polycystic ovary
syndrome, oligo amenorrhoea and subfertility. Cochrane Database
Syst Rev. 11(CD003053)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cataldo NA, Barnhart HX, Legro RS, Myers
ER, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP,
Coutifaris C, et al: Extended-release metformin does not reduce the
clomiphene citrate dose required to induce ovulation in polycystic
ovary syndrome. J Clin Endocrinol Metab. 93:3124–3127.
2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chen X, He S and Wang D: Effects of
metformin on body weight in polycystic ovary syndrome patients:
Model-based meta-analysis. Expert Rev Clin Pharmacol. 14:121–130.
2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Abu Hashim H: Twenty years of ovulation
induction with metformin for PCOS; what is the best available
evidence? Reprod Biomed Online. 32:44–53. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Malik M, Tasnim N and Mahmud G: Effect of
metformin alone compared with metformin plus simvastatin on
polycystic ovarian syndrome in Pakistani women. J Coll Physicians
Surg Pak. 28:184–187. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
DiNicolantonio JJ and O'Keefe JH:
Myo-inositol for insulin resistance, metabolic syndrome, polycystic
ovary syndrome and gestational diabetes. Open Heart.
9(e001989)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chandrasekaran S and Sagili H: Metabolic
syndrome in patients with polycystic ovary syndrome. Obstet
Gynaecol. 20:245–252. 2018.
|
|
13
|
Caprio F, D'Eufemia MD, Trotta C,
Campitiello MR, Ianniello R, Mele D and Colacurci N: Myo-inositol
therapy for poor-responders during IVF: A prospective controlled
observational trial. J Ovarian Res 8: Article. 8(37)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zain MM, Jamaluddin R, Ibrahim A and
Norman RJ: Comparison of clomiphene citrate, metformin, or the
combination of both for first-line ovulation induction, achievement
of pregnancy, and live birth in Asian women with polycystic ovary
syndrome: A randomized controlled trial. Fertil Steri. 91:514–521.
2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sterne JAC, Savović J, Page MJ, Elbers RG,
Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge
SM, et al: RoB 2: A revised tool for assessing risk of bias in
randomised trials. BMJ. 366(l4898)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kamenov Z, Kolarov G, Gateva A, Carlomagno
G and Genazzani AD: Ovulation induction with myo-inositol alone and
in combination with clomiphene citrate in polycystic ovarian
syndrome patients with insulin resistance. Gynecol Endocrinol.
31:131–135. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Parveen S, Iram N, Saeed BZ, Yaqub U and
Niazi NK: Clomiphene supported ovulation induction in subfertile
polycystic ovary syndrome women: Role of different insulin
sensitizers. Pak Armed Forces Med J. 73(810)2023.
|
|
18
|
Rolland AL, Peigné M, Plouvier P, Dumont
A, Catteau-Jonard S and Dewailly D: Could myo-inositol soft gel
capsules outperform clomiphene in inducing ovulation? Results of a
pilot study. Eur Rev Med Pharmacol Sci. 21 (Suppl 2):S10–S14.
2017.PubMed/NCBI
|
|
19
|
Taş M and Özçelik B: Does the combination
of myo-inositol improve pregnancy outcomes in obese polycystic
ovary syndrome women undergoing ovarian stimulation with clomiphene
citrate? J Surg Med. 3:707–710. 2019.
|
|
20
|
Nakamura Y, Ono M, Yoshida Y, Sugino N,
Ueda K and Kato H: Effects of clomiphene citrate on the endometrial
thickness and echogenic pattern of the endometrium. Fertil Steril.
67:256–260. 1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
ESHRE Capri Workshop Group. Health and
fertility in World Health Organization group 2 anovulatory women.
Hum Reprod Update. 18:586–599. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Palomba S, Piltonen TT and Giudice LC:
Endometrial function in women with polycystic ovary syndrome: A
comprehensive review. Hum Reprod Update. 27:584–618.
2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hamilton-Fairley D, Kiddy D, Watson H,
Paterson C and Franks S: Association of moderate obesity with a
poor pregnancy outcome in women with polycystic ovary syndrome
treated with low dose gonadotrophin. Br J Obstet Gynaecol.
99:128–131. 1992.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kumar P, Nawani N, Malhotra N, Malhotra J,
Patil M, Jayakrishnan K, Kar S, Jirge PR and Mahajan N: Assisted
reproduction in polycystic ovarian disease: A multicentric trial in
India. J Hum Reprod Sci. 6:49–53. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Siristatidis CS, Maheshwari A, Vaidakis D
and Bhattacharya S: In vitro maturation in subfertile women with
polycystic ovarian syndrome undergoing assisted reproduction.
Cochrane Database Syst Rev: CD006606, 2013.
|
|
26
|
Pundir J, Psaroudakis D, Savnur P, Bhide
P, Sabatini L, Teede H, Coomarasamy A and Thangaratinam S: Inositol
treatment of anovulation in women with polycystic ovary syndrome: A
meta-analysis of randomised trials. BJOG. 125:299–308.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kousta E, White DM and Franks S: Modern
use of clomiphene citrate in induction of ovulation. Hum Reprod
Update. 3:359–365. 1997.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Massai MR, de Ziegler D, Lesobre V,
Bergeron C, Frydman R and Bouchard P: Clomiphene citrate affects
cervical mucus and endometrial morphology independently of the
changes in plasma hormonal levels induced by multiple follicular
recruitment. Fertil Steril. 59:1179–1186. 1993.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Emekçi Özay Ö, Özay AC, Çağlıyan E, Okyay
RE and Gülekli B: Myo-inositol administration positively effects
ovulation induction and intrauterine insemination in patients with
polycystic ovary syndrome: A prospective, controlled, randomized
trial. Gynecol Endocrinol. 33:524–528. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Benelli E, Del Ghianda S, Di Cosmo C and
Tonacchera M: A combined therapy with Myo-Inositol and
D-Chiro-Inositol improves endocrine parameters and insulin
resistance in PCOS young overweight women. Int J Endocrinol.
2016(3204083)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gerli S, Mignosa M and Di Renzo GC:
Effects of inositol on ovarian function and metabolic factors in
women with PCOS: A randomized double blind placebo-controlled
trial. Eur Rev Med Pharmacol Sci. 7:151–159. 2023.PubMed/NCBI
|
|
32
|
Etrusco A, Laganà AS, Chiantera V,
Buzzaccarini G and Unfer V: Myo-inositol in assisted reproductive
technology from bench to bedside. Trends Endocrinol Metab.
35:74–83. 2024.PubMed/NCBI View Article : Google Scholar
|
